Pharmaceutical industry
Resource Information
The concept Pharmaceutical industry represents the subject, aboutness, idea or notion of resources found in University of Missouri Libraries.
The Resource
Pharmaceutical industry
Resource Information
The concept Pharmaceutical industry represents the subject, aboutness, idea or notion of resources found in University of Missouri Libraries.
- Label
- Pharmaceutical industry
- Authority link
- http://id.worldcat.org/fast/01060129
- Source
- fast
135 Items that share the Concept Pharmaceutical industry
Context
Context of Pharmaceutical industrySubject of
No resources found
No enriched resources found
- A Status report, accessibility and affordability of prescription drugs for older Americans (annotated) : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate
- A Status report, accessibilty and affordability of prescription drugs for older Americans : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate
- Administered prices : drugs : Report of the Committee on the Judiciary, United States Senate, made by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52
- AmerisourceBergen Corporation
- Antares Pharma, Inc.
- Auxilium Pharmaceuticals, Inc.
- Biotechnology, breakthrough drugs, and health care reform : lessons from the NIH-university-industry relationship
- Blockbuster drugs : the rise and decline of the pharmaceutical industry
- Chemicals and drugs
- Code blue : inside America's medical industrial complex
- Competition in the drug industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, first session, March 10, 1981
- Competition in the pharmaceutical industry : the declining profitability of drug innovation
- Competition in the pharmaceutical marketplace : antitrust implications of patent settlements : hearing before the Committee on the Judiciary, United States Senate, One Hundred Seventh Congress, first session, May 24, 2001
- Competitive problems in the drug industry : Federal drug procurement and purchase policies, summary and analysis : [prepared for] Select Committee on Small Business, United States Senate, Subcommittee on Monopoly
- Competitive problems in the drug industry : chloramphenicol (chloromycetin) : summary and analysis
- Competitive problems in the drug industry : psychotropic drugs : summary and analysis
- Competitive problems in the drug industry : summary and analysis
- Competitive problems in the pharmaceutical drug industry : hearing before the Subcommittee on Antitrust, Monopolies [sic], and Business Rights of the Committee on the Judiciary, United States Senate, One Hundredth Congress, first session, on the generic drug industry and its concerns with respect to competition from the brand name manufacturers, October 21, 1987
- Competitive strategies in the pharmaceutical industry
- Competitiveness and death : trade and politics in cars, beef, and drugs
- Complete accounts of integrated drug discovery and development : recent examples from the pharmaceutical industry
- Contempt proceedings against Secretary of HEW, Joseph A. Califano, Jr : business meeting of the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session
- Continuous manufacturing for the modernization of pharmaceutical production : proceedings of a workshop
- Contract research and manufacturing services (CRAMS) in India : the business, legal, regulatory and tax environment in the pharmaceutical and biotechnology sectors
- Countering the problem of falsified and substandard drugs
- Covance Inc
- Creating a lean R & D system : lean principles and approaches for pharmaceutical and research-based organizations
- Creating and Restoring Equal Access to Equivalent Samples Act of 2019 : report (to accompany H.R. 965) (including cost estimate of the Congressional Budget Office)
- Crystallization of organic compounds : an industrial perspective
- Current industrial reports, M28G, Shipments of pharmaceutical preparations, except biologicals
- Defense procurement of foreign-made drugs : military operations subcommittee staff memorandum, with federal agency and other commentary
- Diet pill industry : Hearings, Ninetieth Congress, second session, pursuant to S. Res. 26
- Domestic Chemical Diversion Control Act of 1993 : P.L. 103-200, 107 Stat. 2333, December 17, 1993
- Drug development and marketing : [papers and proceedings of] a conference
- Drug discovery today, Therapeutic strategies
- Drug diversion : prescription drug diversion and the American consumer : what you think you see may not be what you get : a staff report
- Drug pricing : poor prescription for consumers and taxpayers? : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Third Congress, second session, July 27, 1994
- Drug products, labeling, packaging, regulation
- Drug regulation and innovation : empirical evidence and policy options
- Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ..
- Drug store news
- Drugs and health : economic issues and policy objectives
- Drugs, soaps and toiletries industry yearbook
- Economic report on antibiotics manufacture, June 1958
- Economic report on antibiotics manufacture, June 1958
- Eli Lilly and Company
- Endo Pharmaceuticals Holdings Inc.
- EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
- Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, generic drug entry prior to patent expiration : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002
- FDA Export Reform and Enhancement Act of 1995 : hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session on S. 593 ... July 13, 1995
- FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995
- Federal Government still striving to establish single drug procurement system : summary : report to the chairman, Committee on the Judiciary, United States Senate
- Fiercepharmamanufacturing.com
- Food and Drug Administration : effect of user fees on drug approval times, withdrawals, and other agency activities
- Food and Drug Administration's Critical Path Initiative : hearing before a subcommittee of the Committee on Appropriations, United States Senate; One Hundred Tenth Congress, first session; special hearing: June 1, 2007; Salt Lake City, Utah
- Food and drug act amendment, relating to exports : Hearings, Eighty-first Congress, first session on H.R. 562. July 25 and August 8, 1949
- Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002
- Genome-based therapeutics : targeted drug discovery and development : workshop summary
- Global IP news, Pharmaceutical patent news
- Health for sale
- Health reform and pharmaceutical innovation
- Hospira Inc
- How health care reform affects pharmaceutical research and development
- How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry
- How to improve the procurement and supply of drugs in the Federal Government : report to the Congress [on the] Department of Defense, Veterans Administration, Department of Health, Education, and Welfare, Office of Management and Budget [and] General Services Administration,
- Journal of generic medicines
- Kendle International Inc
- Life science today
- Making medicines in Africa : the political economy of industrializing for local health
- Man-in-the-plant : FDA's failure to regulate deceptive drug labeling : hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978
- Mediceo Paltac Holdings Co., Ltd
- Merck KGaA
- National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020 : report (to accompany H.R. 4866)
- Noven Pharmaceuticals Inc
- OTC pharmaceuticals in Saudi Arabia
- OTC pharmaceuticals in United Arab Emirates
- Omnicare, Inc
- Orange Book Transparency Act of 2019 : report (to accompany H.R. 1503) (including cost estimate of the Congressional Budget Office)
- Oversight of the Food and Drug Administration's progress in reducing unnecessary paperwork burdens upon small business : hearing before the Subcommittee on Government Programs of the Committee on Small Business, House of Representatives, One Hundred Fourth Congress, second session, Washington, DC, July 24, 1996
- Pay to delay : are patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009
- Paying off generics to prevent competition with brand name drugs : should it be prohibited? Hearing before the Committee on the Judiciary, United States Senate; One Hundred Tenth Congress, first session; January 17, 2007
- Perspectives on pharmaceutical pricing practices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, September 19, 1996
- Pharmaceutical marketplace reform : is competition the right prescription? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, November 16, 1993
- Pharmaceutical patent settlements : issues in innovation and competitiveness
- Pharmaceutical price regulation : national policies versus global interests
- Pharmaceutical science to improve the human condition : winners and finalists for the Prix Galien USA Awards 2013
- Pharmaceutical technology Asia Pacific
- Pharmaceuticals in New Zealand
- Pharmaceuticals, biotechnology & life sciences in Global
- Pharmacy benefit managers
- Polydrug abuse-the response of the medical profession and the pharmaceutical industry : a report of the Select Committee on Narcotics Abuse and Control, Ninety-fifth Congress, second session
- Preclinical and clinical testing by the pharmaceutical industry, 1979 : hearing before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session, on examination of the process of drug testing and FDA's role in the process, October 11, 1979
- Preliminary report of the survey on drugs for rare disease
- Prescription Drug Sunshine, Transparency, Accountability and Reporting Act : report (to accompany H.R. 2113) (including cost estimate of the Congressional Budget Office)
- Prescription Drug User Fee Act of 1992 : P.L. 102-571 : 106 Stat. 4491 : October 29, 1992
- Prescription drug advertising to consumers : staff report
- Prescription drug diversion and counterfeiting : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first-[second] session
- Prescription drug price increases : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985
- Prescription drug programs for older Americans : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate
- Prescription for the people : an activist's guide to making medicine affordable for all
- Prices, markets, and the pharmaceutical revolution
- Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993
- Ranbaxy Laboratories Limited
- Reasonable Rx : solving the drug price crisis
- Regulation and drug development
- Report of the Delegation to South America (April 10 to April 18, 1987) together with supplemental views
- STADA Arzneimittel AG
- Safety and soundness standards in the mail order prescription industry : hearings before the Subcommittee on Government Efficiency, Federalism, and the District of Columbia of the Committee on Governmental Affairs, United States Senate, One Hundredth Congress, first session, August 5, 6, 1987
- Shortages of prescription drugs, 1974 : joint hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-third Congress, second session ... December 5, 1974
- Skyrocketing prescription drug prices : hearings before the Special Committee on Aging, United States Senate, One Hundred First Congress, first session, Washington, DC ... July 18, 1989 ... November 16, 1889
- Tamro Oyj
- The Hatch-Waxman Act : legislative changes in the 108th Congress affecting pharmaceutical patents
- The International supply of medicines : implications of U.S. regulatory reform
- The Prescription Drug User Fee Act : history through the 2007 PDUFA IV reauthorization
- The WTO, intellectual property rights, and the access to medicines controversy
- The antibiotic era : reform, resistance, and the pursuit of a rational therapeutics
- The doc and the duchess : the life and legacy of George H.A. Clowes
- The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003
- The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1993
- The generic drug maze : speeding access to affordable life-saving drugs : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, July 20, 2006
- The global pharmaceutical industry : the demise and the path to recovery
- The impact of medical device and drug regulation on innovation, jobs, and patients : a local perspective : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, September 26, 2011
- The law of drugs and druggists : a treatise with text, cases, statutes, readings, and digests for schools of pharmacy, retail, wholesale, and manufacturing druggists,
- The licit importation of opium : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, One Hundred First Congress, second session, February 27, 1990
- The price of health : the modern pharmaceutical enterprise and the betrayal of a history of care
- The untold story of the drug hearings
- U.S. Oncology, Inc
- U.S. international trade performance and outlook : competitive position in the automotive, aerospace, and chemical and pharmaceutical sectors : hearings before the Subcommittee on Trade of the Committee on Ways and Means, House of Representatives, One Hundred Second Congress, second session, March 11, 23, 30, 31 ; and April 7, 1992
- UCB SA
- Uncertain returns : the multimillion dollar market in reimported pharmaceuticals : a staff report
- User fees for prescription drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992
- User fees for the Food and Drug Administration : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second session, on examining proposed legislation to authorize the Food and Drug Administration to charge user fees to prescription drug manufacturers to increase resources to improve the review time on drug applications, September 22, 1992
- What we can do about drug abuse
- Yakult Honsha Co., Ltd
- You and your foods, drugs and cosmetics
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.missouri.edu/resource/oYmyzCOEXwY/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.missouri.edu/resource/oYmyzCOEXwY/">Pharmaceutical industry</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.missouri.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.missouri.edu/">University of Missouri Libraries</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Concept Pharmaceutical industry
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.missouri.edu/resource/oYmyzCOEXwY/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.missouri.edu/resource/oYmyzCOEXwY/">Pharmaceutical industry</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.missouri.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.missouri.edu/">University of Missouri Libraries</a></span></span></span></span></div>
